DS
SIOX

David Shaw’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

David Shaw’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-23,028
Closed -$8K – 5704
2022
Q2 		$8K Buy
+23,028
New +$9.53K ﹤0.01% 5178
2021
Q2 		– Sell
-165,235
Closed -$431K – 5117
2021
Q1 		$431K Buy
+165,235
New +$467K ﹤0.01% 3570
2020
Q3 		– Sell
-161,702
Closed -$456K – 4278
2020
Q2 		$456K Buy
161,702
+66,859
+70% +$214K ﹤0.01% 3430
2020
Q1 		$231K Buy
94,843
+69,750
+278% +$252K ﹤0.01% 3588
2019
Q4 		$128K Buy
+25,093
New +$139K ﹤0.01% 3859
2018
Q1 		– Sell
-9,047
Closed -$381K – 3857
2017
Q4 		$381K Sell
9,047
-277
-3% -$12.4K ﹤0.01% 3121
2017
Q3 		$513K Sell
9,324
-201,593
-96% -$34M ﹤0.01% 2892
2017
Q2 		$39.1M Buy
210,917
+19,409
+10% +$3.4M 0.06% 361
2017
Q1 		$22.9M Buy
191,508
+866
+0.5% +$90.8K 0.04% 516
2016
Q4 		$18.9M Sell
190,642
-2,069
-1% -$218K 0.03% 649
2016
Q3 		$21.6M Buy
192,711
+975
+0.5% +$117K 0.04% 544
2016
Q2 		$19.7M Buy
191,736
+2,797
+1% +$280K 0.04% 554
2016
Q1 		$17.4M Sell
188,939
-12,323
-6% -$1.31M 0.03% 598
2015
Q4 		$29M Sell
201,262
-44,288
-18% -$5.76M 0.04% 480
2015
Q3 		$25.4M Buy
245,550
+26,800
+12% +$3.14M 0.04% 530
2015
Q2 		$35.7M Buy
+218,750
New +$37.1M 0.05% 423

Other funds holding SIOX

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
TVWM
Tower View Wealth Management Shorewood, Wisconsin $227M AUM 41.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
PCA
Private Capital Advisors Darien, Connecticut $1.14B AUM 48.66% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $214M AUM 45.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return

David Shaw's SIOX Position: Q3 2022 in Review

David Shaw sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q3 2022, closing a stake of 23,028 shares — an estimated $8K sold.

David Shaw first reported a position in SIOX in Q2 2015 and held it in 16 quarters. The position peaked at $39.1M in Q2 2017. 40 funds tracked by Wall St. Rank hold SIOX as of Q3 2022.

  • David Shaw reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • David Shaw sold 23,028 Sio Gene Therapies Inc. Common Stock shares in Q3 2022, an estimated $8K.
  • David Shaw first reported a position in Sio Gene Therapies Inc. Common Stock in Q2 2015 and held it in 16 quarters.
  • David Shaw's Sio Gene Therapies Inc. Common Stock position peaked at $39.1M in Q2 2017.
  • 40 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q3 2022.

Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.